DCE属性开发调查医用大麻供应的公共政策
Katrina Gething1,2, Daniel Erku1,2, Paul Scuffham1,2
1Centre for Applied Health Economics, School of Medicine and Dentistry, Griffith University, Nathan, Australia.
Journal of medical economics
|September 19, 2024
概括
在医用大麻 (MC) 等不熟悉的健康主题上开发离散选择实验 (DCE) 的属性需要采用多方法方法. 这项研究完善了公众偏好研究的属性,确保了清晰度和利益相关者的相关性.
科学领域:
- 卫生政策研究 卫生政策研究
- 消费者行为分析分析
- 医学大麻研究 医学大麻研究
背景情况:
- 定义离散选择实验 (DCE) 的属性对于新产品来说是具有挑战性的,因为信息有限.
- 利益相关者的知识差距阻碍了DCE中有效的属性和水平选择.
- 本研究涉及DCE在医用大麻 (MC) 健康政策方面的属性发展.
研究的目的:
- 概述一个全面的过程,用于识别DCE中的属性和级别.
- 为了衡量与医用大麻 (MC) 相关的健康政策的公众偏好.
- 在不熟悉的产品偏好研究中开发一种强大的属性生成方法.
主要方法:
- 采用了四个阶段的属性开发过程.
- 阶段包括范围审查,焦点小组,德尔菲研究和大声思考采访.
- 方法被代地应用,以改进医用大麻政策上的DCE的属性.
主要成果:
- 范围审查和文档分析提供了一个强大的初始属性列表.
- 焦点小组有效地吸引了具有有限事先知识的参与者.
- "大声思考"采访对于完善属性语言和评估清晰度至关重要.
结论:
- 开发DCE属性对于不熟悉的健康产品,多方法方法是必不可少的.
- 精细的属性对利益相关者来说很重要,促进了权衡,并且被清楚地传达.
- 这个过程确保属性是相关的,可理解的,可用于偏好测量.
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
145
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
145
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Prescription, Nonprescription and Orphan Drugs
704
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
704
Drug Nomenclature
1.7K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.7K
Additional Routes of Drug Administration
2.7K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
2.7K
Dose-Response Relationship: Potency and Efficacy
4.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.3K


